Upgrade to SI Premium - Free Trial

Kiora Pharmaceuticals (KPRX)

2.63 -0.03 (1.13%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/7/26)

Latest Headlines

Form 4 KIORA PHARMACEUTICALS For: Jul 01 Filed by: Tosca Melissa July 2, 2026 4:47 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jul 01 Filed by: Strem Brian M. July 2, 2026 4:47 PM - SEC Filing Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium July 2, 2026 7:02 AM - StreetInsider Form 8-K KIORA PHARMACEUTICALS For: Jun 18 June 18, 2026 7:03 AM - SEC Filing Kiora Pharmaceuticals reports KIO-300 reduced seizure activity in lab model June 18, 2026 7:03 AM - StreetInsider Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model June 18, 2026 7:02 AM - StreetInsider Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: Stengone Carmine N. June 12, 2026 4:16 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: Parsons Erin June 12, 2026 4:16 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: Shapiro Aron June 12, 2026 4:16 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: Hollander David June 12, 2026 4:16 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: Walters-Hoffert Lisa June 12, 2026 4:16 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: TYLE PRAVEEN June 12, 2026 4:14 PM - SEC Filing Form 8-K KIORA PHARMACEUTICALS For: Jun 10 June 11, 2026 6:02 AM - SEC Filing Form 424B3 KIORA PHARMACEUTICALS May 28, 2026 5:52 PM - SEC Filing Form EFFECT KIORA PHARMACEUTICALS May 26, 2026 6:04 AM - SEC Filing Kiora Pharmaceuticals (KPRX) files for 11.9M share offering by selling stockholders May 18, 2026 4:46 PM - StreetInsider Form S-3 KIORA PHARMACEUTICALS May 18, 2026 4:32 PM - SEC Filing Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: Nantahala Capital Management, LLC May 15, 2026 4:45 PM - SEC Filing Form SCHEDULE 13G KIORA PHARMACEUTICALS Filed by: Alyeska Investment Group, L.P. May 15, 2026 4:42 PM - SEC Filing Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: Nantahala Capital Partners Limited Partnership May 15, 2026 4:37 PM - SEC Filing Kiora Pharmaceuticals (KPRX) Misses Q1 EPS by 58c May 8, 2026 8:19 AM - StreetInsider Form 8-K KIORA PHARMACEUTICALS For: May 08 May 8, 2026 7:08 AM - SEC Filing Form 10-Q KIORA PHARMACEUTICALS For: Mar 31 May 8, 2026 7:07 AM - SEC Filing Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update May 8, 2026 7:01 AM - StreetInsider Form ARS KIORA PHARMACEUTICALS For: Dec 31 May 1, 2026 4:02 PM - SEC Filing Form DEF 14A KIORA PHARMACEUTICALS For: Apr 16 April 30, 2026 5:11 PM - SEC Filing Form D KIORA PHARMACEUTICALS April 21, 2026 4:47 PM - SEC Filing Kiora Pharmaceuticals publishes phase 1 retinitis pigmentosa study data April 14, 2026 7:02 AM - StreetInsider Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway April 14, 2026 7:01 AM - StreetInsider Form 8-K KIORA PHARMACEUTICALS For: Apr 03 April 7, 2026 12:43 PM - SEC Filing Kiora Pharmaceuticals closes $24 million private placement April 7, 2026 7:01 AM - StreetInsider Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors April 7, 2026 7:01 AM - StreetInsider Full Article List